Your browser doesn't support javascript.
loading
Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson's Disease: Preclinical and Clinical Studies.
Hong, Chien-Tai; Chan, Lung; Chen, Kai-Yun; Lee, Hsun-Hua; Huang, Li-Kai; Yang, Yu-Chen S H; Liu, Yun-Ru; Hu, Chaur-Jong.
Affiliation
  • Hong CT; Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
  • Chan L; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Chen KY; Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
  • Lee HH; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Huang LK; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Yang YSH; Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
  • Liu YR; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Hu CJ; Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
Cells ; 11(21)2022 11 02.
Article in En | MEDLINE | ID: mdl-36359864

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Gastrointestinal Microbiome Limits: Animals Language: En Journal: Cells Year: 2022 Document type: Article Affiliation country: Taiwán Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Gastrointestinal Microbiome Limits: Animals Language: En Journal: Cells Year: 2022 Document type: Article Affiliation country: Taiwán Country of publication: Suiza